PARTICIPANT PROFILE · SEC DISCLOSURES
H.C. Wainwright & Co..
Service Provider · 7 transactions · 7 issuers in the database
Transaction history
Roles below apply to each specific transaction. Participation is supported by the linked transaction sources.
| Compare | Date | Company | Deal | Gross proceeds | Role on this deal |
|---|---|---|---|---|---|
| Sep 29, 2026SEC disclosed | Largo Inc.LGO | Registered Direct | $5.7M | Placement Agent | |
| Sep 21, 2026SEC disclosed | Knightscope, Inc.KSCP | ATM · Amendment1 note | No cash proceeds | Sales Agent | |
| Sep 14, 2026SEC disclosed | Laser Photonics CorpLASE | Best-Efforts Offering | $7.9M | Exclusive Placement Agent | |
| Sep 8, 2026 | Lexaria Bioscience Corp.LEXX | Warrant Inducement1 note | $5.9M | Exclusive Placement Agent | |
| Sep 4, 2026SEC disclosed | Virax Biolabs Group LtdVRAX | ATM · Amendment1 note | No cash proceeds | Sales Agent | |
| Aug 31, 2026SEC disclosed | Indaptus Therapeutics, Inc.INDP | ATM · Replacement1 note | No cash proceeds | Sales Agent | |
| Apr 1, 2026 | Hoth Therapeutics, Inc.HOTH | Registered Direct | $2.0M | Exclusive Placement Agent |
SEC deal terms · FMP market data where available · Initial research sample, not complete market coverage. AI-assisted source review; original evidence is available in each report. Names and tickers reflect the transaction date. A dash (—) means the value is unavailable.